Work

Naxitamab: a humanized anti-glycolipid disialoganglioside (anti-GD2) monoclonal antibody for treatment of neuroblastoma

Year: 2021

Type: article

Source: Drugs of today

DOI: 10.1358/dot.2021.57.11.3343691

Authors: Slatnick, L.R., Jimeno, A., Gore, L., Macy, M.E.

Institutions: Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Cancer Center

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3216791110

FWCI: 0.956

Cites:

Cited by: 15

Related to: 10